T1	Participants 530 642	118 evaluable patients: 32 in the laser-CO2 group, 34 in the 5-fluorouracil group and 52 in the interferon group
T2	Participants 71 125	two candidate regimens (5-fluorouracil and interferon)
T3	Participants 17 38	condylomata acuminata
